WuXi AppTec

WuXi AppTec operates as a global Contract Research, Development, and Manufacturing Organization (CRDMO), delivering integrated, end-to-end services across the pharmaceutical and life sciences industries. The company provides a comprehensive suite of R&D and manufacturing solutions, spanning chemistry drug CRDMO, biology discovery, preclinical testing, and clinical research services, designed to support the entire drug development lifecycle from early discovery through commercial manufacturing. This integrated platform aims to enhance efficiency and accelerate the advancement of new therapies.

The company was founded in 2000 by Dr. Ge Li, who serves as its Chairman and CEO. Dr. Li, along with three co-founders, established WuXi AppTec based on the foundational belief that every drug can be made and every disease can be treated. Starting from a modest laboratory, their vision was to create a partner that could simplify and expedite the complex process of bringing new medicines to patients.

WuXi AppTec serves a broad base of innovators within the pharmaceutical and life sciences sectors across numerous countries. The company's long-term vision is centered on enabling breakthroughs in healthcare, working to ensure that scientific discoveries are translated into accessible treatments. It continuously aims to empower its partners in their pursuit of developing life-saving medications for patients worldwide.